false
0001527352
0001527352
2026-08-11
2026-08-11
iso4217:USD
xbrli:shares
iso4217:USD
xbrli:shares
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
PURSUANT TO SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported):
August 11, 2026
NEXALIN TECHNOLOGY, INC.
(Exact name of registrant as specified in its charter)
| Delaware |
|
001-41507 |
|
27-5566468 |
(State or other jurisdiction
of incorporation) |
|
(Commission
File Number) |
|
(IRS Employer
Identification No.) |
1776
Yorktown Street, Suite
550
Houston, TX 77056
Registrant’s telephone
number, including area code: (832) 260-0222
(Former name or former address, if changed since last report)
Check the appropriate box below if the Form 8-K
filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| ☐ |
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| |
|
| ☐ |
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| |
|
| ☐ |
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b)
of the Act:
| Title of each class |
|
Trading Symbol(s) |
|
Name of each exchange on which registered |
| Common Stock, par value $0.001 per share |
|
NXL |
|
The Nasdaq Stock Market LLC |
Indicate by check mark whether the registrant
is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the
Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☒
If an emerging growth company, indicate by check
mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting
standards provided pursuant to Section 13(a) of the Exchange Act.
| Item
5.07 | Submission
of Maters to a Vote of Security Holders. |
The
annual meeting (the “Annual Meeting”) of the stockholders of Nexalin Technology, Inc. (the “Company”) was convened
at 10:00 a.m. Eastern time on August 11, 2026. Of the 22,011,302 shares of the Company’s common stock, par value $0.001 per share
(the “common stock”), outstanding at the close of business on July 6, 2026, the record date for the Annual Meeting, 13,912,110
shares of common stock were present or represented by proxy at the Annual Meeting, which amounts to approximately 63.2% of the shares
of the Company’s common stock outstanding and entitled to vote. As a result, quorum was met. At the Annual Meeting, the Company’s
stockholders voted on the six proposals described below. The results of the items voted on at the Annual Meeting are as follows.
Item One: Election of five directors of the Company:
| Name |
For |
Withheld |
Broker
Non-Votes |
| Leslie
Bernhard |
8,705,295 |
432,207 |
4,774,608 |
| Mark
White |
8,840,686 |
296,816 |
4,774,608 |
| David
Owens, M.D. |
8,785,477 |
352,025 |
4,774,608 |
| Alan
Kazden |
8,790,402 |
347,100 |
4,774,608 |
| Ben
V. Hu, M.D. |
8,763,598 |
373,904 |
4,774,608 |
Item Two: Approval of the Company’s 2026 Equity Incentive Plan:
| For |
Against |
Abstain |
Broker
Non-Votes |
| 8,248,630 |
815,467 |
73,405 |
4,774,608 |
Item Three: Approval of one or more amendments of the Company’s Second Amended and Restated Certificate of Incorporation to effect one or more reverse stock splits of the Company’s Common Stock, at a ratio ranging from any whole number between and including 1-for-2 and 1-for-100 and in the aggregate not more than 1-for-250, inclusive, as determined by the Company’s board of directors in its discretion, subject to the authority of the board of directors to abandon such amendments:
| For |
Against |
Abstain |
| 12,458,652 |
1,401,464 |
51,994 |
Item Four: Approval and adoption of an Amendment to the Amended and Restated Certificate of Incorporation of the Company to authorize 10 million shares of preferred stock:
| For |
Against |
Abstain |
Broker Non-Votes |
| 7,863,517 |
1,208,690 |
65,295 |
4,774,608 |
Item Five: Approval and adoption of an Amendment to the Amended and Restated Certificate of Incorporation of the Company to provide for Officer Exculpation:
| For |
Against |
Abstain |
Broker Non-Votes |
| 8,239,359 |
772,759 |
125,384 |
4,774,608 |
Item Six: Ratification of the appointment of CBIZ CPAS P.C. as the Company’s independent registered public accounting firm for the year ending December 31, 2026:
| For |
Against |
Abstain |
| 13,362,297 |
430,308 |
119,505 |
Based on the foregoing votes, the director nominees
listed in Item 1 were elected, and Items 2, 3, and 6 were approved. Items 4 and 5 were not approved. No other items were presented for
stockholder approval at the Annual Meeting.
SIGNATURE
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report on form 8-K to be signed on its behalf by the undersigned hereunto duly
authorized.
| |
NEXALIN TECHNOLOGY, INC. |
| |
|
|
| |
By: |
/s/ Mark White |
| |
|
Mark White |
| |
|
Chief Executive Officer |
| |
|
|
| Dated: August 11, 2026 |
|
|